๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

โœ Scribed by Miller, Stephen D.; Turley, Danielle M.; Podojil, Joseph R.


Book ID
109955751
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
972 KB
Volume
7
Category
Article
ISSN
1474-1741

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Dendritic cells in tolerance induction f
โœ Maria Rescigno ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 248 KB ๐Ÿ‘ 2 views

## Abstract Autoimmune diseases are characterized by the loss of tolerance toward selfโ€antigens and the induction of destructive immune responses leading to tissue damage. Most patients with autoimmune diseases are treated with immunosuppressive drugs that suppress the immune response in a nonโ€spec

The expression of self antigenic determi
โœ Mark J. Mamula; Joe Craft ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 706 KB

T lymphocytes respond to small peptides in the context of major histocompatibility molecules and a host of other cell-surface proteins on antigen-presenting cells. By design, therefore, T-cell responses are dependent on the efficient and accurate processing of both foreign and self peptides by antig

Strategy for the prevention and treatmen
โœ Yunosuke Ogawa; Hiroshi Shimizu; Jiro Takasaki; Toshihiko Nakamura ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 475 KB ๐Ÿ‘ 2 views

Based on the analyses of approximately 1,000 infants with CLD, this condition was classified into 7 types according to the preceding illnesses and the chest X-ray appearance. The profile of inflammatory enzymes, cytokines and chemical mediators supported the relevance of the classification. Since di

Antigen-specific blocking of CD4-Specifi
โœ Prakash Manikwar; Paul Kiptoo; Ahmed H. Badawi; Barlas Bรผyรผktimkin; Teruna J. Si ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 552 KB

## Abstract In this review, we discuss Tโ€cell activation, etiology, and the current therapies of autoimmune diseases (i.e., MS, T1D, and RA). Tโ€cells are activated upon interaction with antigenโ€presenting cells (APC) followed by a โ€œbull's eyeโ€โ€like formation of the immunological synapse (IS) at the